DYAI

MKT CAP:$28M

Dyadic International Inc

Market Cap

$28M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.71-$0.23 (-24.46%)

Jun 5, 2026

52W High $1.3052W Low $0.68

Company Details

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a pr...

CEO

—

IPO Date

Nov 5, 2004

Website

www.dyadic.com

Key Metrics TTM

Revenue

$3M

-11.0% YoY

Net Income

-$7M

EPS (Diluted)

Free Cash Flow

-$6M

Revenue / Share

$0.08

Gross Margin

31.3%

Operating Margin

-238.4%

Net Margin

-245.1%

FCF Margin

-192.1%

P/S

9.5x

P/E

Earnings Reports

Q1 2026

May 13, 2026

$1M+506.7%

FY 2025

Mar 25, 2026

$1M-64.7%

Q4 2025

Mar 25, 2026

$235.7K-71.2%

Q3 2025

Nov 12, 2025

$1M-40.5%

Q2 2025

Aug 13, 2025

$463.4K+20.1%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee